hero image
Dr. Patrice

Dr. Patrice "Patrick" Delafontaine

Professor of Medicine/Executive Dean | Tulane University

New Orleans , LA, UNITED STATES

Dr. Patrice “Patrick” Delafontaine is a physician-scientist and COVID-19 expert in interventional cardiology and vascular biology.

Media

Publications:

Documents:

Photos:

Videos:

Dean's Town Hall Meeting Updates on the COVID-19 Virus  03/17/20 Louisiana virus cases rise as more tests are done Social Isolation & Stress: Tulane School of Medicine Community Town Hall Q&A and Medical Update

Audio/Podcasts:

Social

Biography

Dr. Patrice “Patrick” Delafontaine’s research has been continuously funded for over 20 years by the National Institutes of Health. His focus has been growth factors, cellular and molecular biology and atherosclerosis.

His current areas of investigative focus include 1) the Role of IGF I and its Binding Proteins in Vascular Growth and Atherosclerosis; 2) Vascular Smooth Muscle and Endothelial Cell Biology; 3) Unstable Angina and Coronary Atherosclerosis; and 4) Mechanisms of Muscle Wasting in Chronic Disease States.

Dr. Delafontaine has been a member of the Southern Society for Clinical Investigation since 2005, and has served on the Council and Nominating committee. He currently serves on the Mentoring committee and the Speakers Bureau of the Visiting Professor Program of the SSCI.

Dr. Delafontaine has held positions at Emory University, the University of Geneva, the University of Kansas Medical School and Tulane University. During his first tenure at Tulane he was the Vice Chair of Research for the Department of Medicine, Chief of the Section of Cardiology, Director of the Tulane Heart and Vascular Institute and was the Interim Chair of the Department of Medicine. He was also the Director of the NIH funded Louisiana Clinical and Translational Science Center's Clinical Translational Unit at the Tulane University. In December 2014, Dr. Delafontaine was appointed as the Hugh E. and Sarah D. Stephenson Dean at the University of Missouri - Columbia.

Dr. Delafontaine completed his studies and received his Doctorate in Medicine at the University of Geneva in Geneva, Switzerland, and his residency in Internal Medicine at the Hahnemann Medical College and Hospital in Philadelphia, PA. He completed a research and a clinical fellowship program in cardiology at Harvard Medical School and Brigham and Women's Hospital in Boston, Massachusetts.

Areas of Expertise (5)

Physician-Scientist

COVID-10 (Coronavirus)

Cardiology

Interventional Cardiology

Vascular Biology

Accomplishments (12)

A.J. de Cotis Award for Outstanding Medical Resident (professional)

1979

Geneva University Hospital Training Fund Award (professional)

1984

Swiss National Research Fund Award (professional)

1985

American Heart Association - Massachusetts Affiliate Fellowship Award (professional)

1986

American Heart Association - Massachusetts Affiliate Fellowship Award (professional)

1987

Distinguished Achievement Award of the American Heart Association, Georgia Affiliate (professional)

1993

Tinsley Harrison Award of the Southern Society of Clinical Investigation (professional)

1994

Established Investigator Award - American Heart Association (professional)

1994

Research Career Development Award - National Institutes of Health (professional)

1994

Present Elected by his peers for inclusion in Best Doctors in America® (professional)

2001

University of Missouri Columbia International Center for Psychosocial Trauma Annual Humanitarian Award (professional)

2017

Kaley Award Featured Topic: The Microcirculation and Its Many Cells that Contribute to Tissue Repair, (professional)

2019

Education (4)

University of Geneva: MD, Faculty of Medicine

Hahnemann Medical College: Residency, Internal Medcine

Harvard Medical School and Brigham and Women's Hospital: Research and Clinical Fellowship, Cardiology

University of Geneva: BS, Faculty of Sciences and Medicine

Affiliations (3)

  • Southern Society for Clinical Investigation
  • Speakers Bureau of the Visiting Professor Program of the SSCI
  • Louisiana Clinical and Translational Science Center's Clinical Translational Unit

Media Appearances (1)

Tulane School of Medicine launches COVID-19 testing lab to improve capacity

KATC (ABC) Lafayette  online

2020-04-03

Tulane University has added a second avenue for COVID-19 testing, this one taking place at a Tulane School of Medicine repurposed research lab where results can be processed within a day.

view more

Articles (1)

Dr. Patrice "Patrick" Delafontaine Publications

Research Gate

207 Publications

view more